CB-246-6

**CB-246-6**, also designated **CTC-310**, is a Celtic Biotech composite venom-peptide product described for development in pancreatic cancer, colon cancer, and hematological cancers. The corresponding CTC-310 product label describes a sterile homeopathic injectable formulation containing a 1:1 combination of crotoxin preparations derived from *Crotalus durissus* venom and cardiotoxin preparations derived from *Naja naja* venom. It has no established, validated molecular target or clinically proven anticancer mechanism; the product was listed in U.S. labeling as an unapproved homeopathic product that FDA had not evaluated for safety or efficacy. ([homeolabels.com](https://homeolabels.com/lib/remedies/details/ctc-310/))

Other names

crotalus durissus terrificus venom and cardiotoxin III